Search

Your search keyword '"Skowasch, Dirk"' showing total 754 results

Search Constraints

Start Over You searched for: Author "Skowasch, Dirk" Remove constraint Author: "Skowasch, Dirk" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
754 results on '"Skowasch, Dirk"'

Search Results

3. Autorinnen und Autoren

5. Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era

10. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

16. Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease

17. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

18. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

19. Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis

20. German asthma net: Nasal polyposis in patients in the severe asthma registry

21. Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis

26. Disease trajectories in interstitial lung diseases – data from the EXCITING-ILD registry

27. As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort

31. Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry

32. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

33. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

34. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry

36. Early-stage idiopathic pulmonary fibrosis is characterized by bronchoalveolar accumulation of SPP1+macrophages

37. Medikamentöse Therapie der pulmonalarteriellen Hypertonie mit Komorbiditäten – Welche Phänotypen gibt es, was gibt es zu beachten?

38. Pulmonale Hypertonie assoziiert mit Lungenerkrankungen

40. No evidence to support the impact of migration background on treatment response rates and cancer survival: a retrospective matched-pair analysis in Germany

41. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients

42. Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells.

47. Response to biologics and clinical remission in the adult GAN severe asthma cohort.

48. German Asthma Net: Nasal polyposis in patients with severe asthma

49. Impact of smoking on biologicals treatment response in patients from the German Severe Asthma (GAN) Registry

Catalog

Books, media, physical & digital resources